Laboratory Corporation of Ameri – Consensus Indicates Potential 13.2% Upside

Broker Ratings

Laboratory Corporation of Ameri with ticker code (LH) have now 14 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 380 and 215 calculating the mean target price we have 332.86. Now with the previous closing price of 294.16 this indicates there is a potential upside of 13.2%. There is a 50 day moving average of 301.53 while the 200 day moving average is 274.17. The company has a market cap of $28,097m. Find out more information at: http://www.labcorp.com

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women’s health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company has a collaboration agreement with community clinical oncology research network, LLC to understand the impact of disparities in precision medicine for people with cancer. It primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

You might also enjoy reading  Laboratory Corporation of Ameri - Consensus Indicates Potential 21.2% Upside
Share on Stocktwits

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index